Why Are Diabetes Test Strips So Expensive?

Diabetes test strips are often considered expensive due to the high costs associated with their research and development, manufacturing, marketing, and distribution.

Developing new medical devices, such as glucose meters and test strips, requires significant investments in research and development, clinical trials, and regulatory approvals, which are passed on to consumers in the form of higher prices.

Manufacturing diabetes test strips also involves specialized equipment and technology, which adds to the production costs.

In addition, companies must invest in marketing and distribution to reach potential customers, including advertising, sales promotions, and distribution networks, all of which contribute to the cost of the final product.

The cost of diabetes test strips is also influenced by insurance coverage, with some plans requiring patients to pay a deductible or copay for test strips or limiting the number of strips they can receive per month.

However, it is important to note that diabetes test strips are essential for managing blood sugar levels and preventing complications for people with diabetes.

Skipping or reducing the number of tests can lead to poorly controlled blood sugar levels and increased risk of complications, which can lead to even higher healthcare costs in the long run.

Patients should work with their healthcare providers and insurance plans to find cost-effective solutions for managing their diabetes, such as purchasing test strips in bulk or using generic brands.

Basics of Diabetes

Diabetes is a chronic disease that affects millions of people worldwide.

For people with diabetes, monitoring their blood glucose levels is crucial for managing their condition and preventing complications. This is where diabetes test strips come into play.

These small strips are used with a glucose meter to measure blood sugar levels.

However, the cost of diabetes test strips has been a growing concern for people with diabetes, as well as healthcare providers and insurers.

Diabetes Statistics

The incidence of diabetes in the United States has been increasing rapidly in recent years.

According to the Centers for Disease Control and Prevention (CDC), an estimated 37.3 million people, or 11.3% of the U.S. population, had diabetes in 2022.

Prevalence of Diabetes

Diabetes affects all social, economic, and ethnic backgrounds. An estimated 28.7 million people, or 28.5% of the U.S. population, had diagnosed diabetes, while approximately 8.5 million people have diabetes but have not yet been diagnosed.

New Cases of Diabetes in Adults and Children

In 2019, 283,000 children and adolescents younger than age 20 years had diagnosed diabetes, including 244,000 with type 1 diabetes. During 2014-2015, an estimated 18,291 children and adolescents younger than age 20 were newly diagnosed with type 1 diabetes.

Incidence of Diabetes Complications

Diabetes is associated with serious complications, such as heart disease, stroke, blindness, kidney failure, and lower-limb amputation, among other conditions.

In 2018, a total of 8.25 million hospital discharges were reported with diabetes as any listed diagnosis among US adults aged 18 years or older.

Additionally, approximately 17 million emergency department (ED) visits were reported with diabetes as any listed diagnosis among adults aged 18 years or older.

Kidney Disease

Among U.S. adults aged 18 years or older with diagnosed diabetes, the estimated prevalence of chronic kidney disease was 39.2% during 2017-2020. A total of 62,012 people developed end-stage kidney disease with diabetes as the primary cause.

Vision Disability

Diabetes is the leading cause of new cases of blindness among adults aged 18–64 years. Among US adults aged 18 years or older with diagnosed diabetes, approximately 11.8% reported severe vision difficulty or blindness in 2019.

Diabetes Mortality

Diabetes was the seventh leading cause of death in the United States in 2017 based on the 83,564 death certificates in which diabetes was listed as the underlying cause of death. Diabetes was listed as the underlying or contributing cause of death on 270,702 death certificates in 2017.

The Cost of Diabetes

In 2017, the total estimated cost of diagnosed diabetes in the U.S. was $327 billion.

Between 2012 and 2017, excess medical costs per person associated with diabetes increased from $8,417 to $9,601 (2017 dollars).

Factors Contributing to the High Cost of Diabetes Test Strips

Research and Development Costs

Developing new medical devices, such as glucose meters and test strips, involves extensive research and development costs.

These costs are often passed onto consumers in the form of higher prices.

In addition, companies must conduct clinical trials and obtain regulatory approvals from agencies such as the FDA before marketing their products, which can also be expensive.

Manufacturing Costs

Manufacturing diabetes test strips requires specialized equipment and technology.

The production process must be highly precise to ensure accuracy and consistency in glucose readings.

As a result, manufacturing costs are significant, and this is reflected in the price of the final product.

Marketing and Distribution Costs

Companies that manufacture diabetes test strips must also invest in marketing and distribution to reach potential customers.

This includes advertising, sales promotions, and distribution networks, all of which add to the cost of the product.

Insurance Coverage

The cost of diabetes test strips is also influenced by insurance coverage.

Many insurance plans cover the cost of test strips, but the amount and extent of coverage vary widely.

Some insurance plans require patients to meet a deductible or pay a copay for test strips, which can add up to a significant expense over time.

In addition, some plans may limit the number of test strips that patients can receive per month, which can lead to additional out-of-pocket expenses.

Impact of High Diabetes Test Strip Costs

Financial Burden on Patients: For people with diabetes, the cost of test strips can be a significant financial burden. Depending on how often they need to test their blood sugar, the cost can add up quickly.

Some patients may need to test multiple times a day, which can cost hundreds or even thousands of dollars per year.

Non-Compliance with Testing: The high cost of diabetes test strips can also lead to non-compliance with testing regimens.

Patients may skip testing to save money or use fewer test strips than recommended, which can lead to poorly controlled blood sugar levels and increased risk of complications.

Healthcare Costs: When patients with diabetes do not monitor their blood sugar regularly, they are more likely to experience complications such as kidney damage, nerve damage, and eye problems.

These complications can lead to increased healthcare costs, including hospitalizations, surgeries, and medications.

Related Articles

Can You Use Expired Glucometer Test Strips? What You Need to Know

Why You Should Never Reuse Glucometer Strips: The Importance of Proper Use and Disposal

Frequently Asked Questions (FAQs)

Why are some diabetes test strips more expensive than others?

The cost of diabetes test strips can vary depending on the brand, the number of strips in a package, and the technology used in the strips.

Some strips use more advanced technology, such as biosensors, which can contribute to a higher cost.

Can I buy diabetes test strips without a prescription?

In most cases, diabetes test strips require a prescription from a healthcare provider.

However, some pharmacies may sell test strips without a prescription, but patients should check with their insurance plan to determine if they are covered.

Conclusion

While the cost of diabetes test strips may be high, they are essential for managing diabetes effectively and preventing complications.

Patients should work with their healthcare providers and insurance plans to find cost-effective solutions for managing their diabetes, such as purchasing test strips in bulk or using generic brands.

Insurers should also consider expanding coverage for diabetes test strips to reduce the financial burden on patients and promote better diabetes management.